Yahoo Web Search

  1. 4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics

    Zacks via Yahoo FinanceApr 11 13:27 PM

    Biotech bigwig Regeneron Pharmaceuticals, Inc. s REGN recently extended collaboration agreement with Alnylam Pharmaceuticals, Inc. ALNY brought ribonucleic acid interference (RNAi) therapeutics in focus.

  2. ...: ASMB)(presented interim mid-stage results of its hepatitis B virus treatment candidate ABI-H0731) CELLECT BIOTECH/S ADR (NASDAQ: APOP) Conatus Pharmaceuticals Inc (NASDAQ: CNAT)(announced Phase 2 clinical trial evaluating emricasan in NASH patients with cirrhosis and severe portal hypertension) Fennec Pharmaceuticals Inc (NASDAQ: FENC...

  3. This kit will be used as a companion diagnostic to identify patients eligible for the treatment with Janssen Biotech’s fibroblast growth factor receptor (FGFR) kinase inhibitor drug, ...

  4. Edited Transcript of JNJ earnings conference call or presentation 16-Apr-19 12:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceApr 17 16:11 PM

    We recently issued our 2018 Janssen U.S. Transparency Report which is now available on our website. We led the industry by publishing this annual report 3 years ago, and we're proud to ...